134 related articles for article (PubMed ID: 32702999)
1. The prominent value of apparent diffusion coefficient in assessing high-risk factors and prognosis for patients with endometrial carcinoma before treatment.
Quan Q; Lu Y; Xuan B; Wu J; Yin W; Hua Y; Chen R; Ren S; Zhou S; Zhang F; Meng Y; Rao K; Mu X
Acta Radiol; 2021 Jun; 62(6):830-838. PubMed ID: 32702999
[TBL] [Abstract][Full Text] [Related]
2. The Preeminent Value of the Apparent Diffusion Coefficient in Assessing High-Risk Factors and Prognosis for Stage I Endometrial Carcinoma Patients.
Quan Q; Peng H; Gong S; Liu J; Lu Y; Chen R; Mu X
Front Oncol; 2022; 12():820904. PubMed ID: 35251987
[TBL] [Abstract][Full Text] [Related]
3. Utility of the relative apparent diffusion coefficient for preoperative assessment of low risk endometrial carcinoma.
Shen Y; Lv F; Xiao Z; Bi Q
Clin Imaging; 2019; 56():28-32. PubMed ID: 30851496
[TBL] [Abstract][Full Text] [Related]
4. The ability of ADC measurements in the assessment of patients with stage I endometrial carcinoma based on three risk categories.
Liu J; Yuan F; Wang S; Chen X; Ma F; Zhang G; Tian X
Acta Radiol; 2019 Jan; 60(1):120-128. PubMed ID: 29667881
[TBL] [Abstract][Full Text] [Related]
5. Multiple mathematical models of diffusion-weighted imaging for endometrial cancer characterization: Correlation with prognosis-related risk factors.
Zhang Q; Ouyang H; Ye F; Chen S; Xie L; Zhao X; Yu X
Eur J Radiol; 2020 Sep; 130():109102. PubMed ID: 32673928
[TBL] [Abstract][Full Text] [Related]
6. [The value of T2 mapping for evaluating the pathological type, grade and depth of myometrial invasion in endometrial carcinoma].
Li SJ; Zhang ZX; Liu J; Wang WJ; Wang J; Zhang Y; Cheng JL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):673-680. PubMed ID: 37580272
[No Abstract] [Full Text] [Related]
7. The value of the apparent diffusion coefficient in differentiating type II from type I endometrial carcinoma.
Chen J; Fan W; Gu H; Wang Y; Liu Y; Chen X; Ren S; Wang Z
Acta Radiol; 2021 Jul; 62(7):959-965. PubMed ID: 32727213
[TBL] [Abstract][Full Text] [Related]
8. Volumetric apparent diffusion coefficient (ADC) histogram metrics as imaging biomarkers for pretreatment predicting response to fertility-sparing treatment in patients with endometrial cancer.
Ma X; Ren X; Ma F; Cai S; Ning C; Liu J; Chen X; Zhang G; Qiang J
Gynecol Oncol; 2022 Jun; 165(3):594-602. PubMed ID: 35469683
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of diffusion-kurtosis imaging for grading endometrial carcinoma: a comparative study with diffusion-weighted imaging.
Chen T; Li Y; Lu SS; Zhang YD; Wang XN; Luo CY; Shi HB
Clin Radiol; 2017 Nov; 72(11):995.e11-995.e20. PubMed ID: 28774471
[TBL] [Abstract][Full Text] [Related]
10. Is the standard deviation of the apparent diffusion coefficient a potential tool for the preoperative prediction of tumor grade in endometrial cancer?
Yan B; Liang X; Zhao T; Ding C; Zhang M
Acta Radiol; 2020 Dec; 61(12):1724-1732. PubMed ID: 32366108
[TBL] [Abstract][Full Text] [Related]
11. The role of volumetric ADC histogram analysis in preoperatively evaluating the tumour subtype and grade of endometrial cancer.
Ma X; Shen M; He Y; Ma F; Liu J; Zhang G; Qiang J
Eur J Radiol; 2021 Jul; 140():109745. PubMed ID: 33962254
[TBL] [Abstract][Full Text] [Related]
12. The apparent diffusion coefficient (ADC) on 3-T MRI differentiates myometrial invasion depth and histological grade in patients with endometrial cancer.
Reyes-Pérez JA; Villaseñor-Navarro Y; Jiménez de Los Santos ME; Pacheco-Bravo I; Calle-Loja M; Sollozo-Dupont I
Acta Radiol; 2020 Sep; 61(9):1277-1286. PubMed ID: 31955608
[TBL] [Abstract][Full Text] [Related]
13. Combined subjective and quantitative analysis of magnetic resonance images could improve the diagnostic performance of deep myometrial invasion in endometrial cancer.
Deng L; Wang QP; Yan R; Yu N; Bai L; Duan XY; Guo YM
Clin Imaging; 2017; 43():69-73. PubMed ID: 28232207
[TBL] [Abstract][Full Text] [Related]
14. Utility of histogram analysis of apparent diffusion coefficient maps obtained using 3.0T MRI for distinguishing uterine carcinosarcoma from endometrial carcinoma.
Takahashi M; Kozawa E; Tanisaka M; Hasegawa K; Yasuda M; Sakai F
J Magn Reson Imaging; 2016 Jun; 43(6):1301-7. PubMed ID: 26605502
[TBL] [Abstract][Full Text] [Related]
15. Evaluation and validation of the diagnostic value of the apparent diffusion coefficient for differentiating early-stage endometrial carcinomas from benign mimickers at 3T MRI.
Wang X; Zhao Y; Hu Y; Zhou Y; Ye X; Liu K; Bai G; Guo A; Du M; Jiang L; Wang J; Yan Z
Oncotarget; 2017 Jul; 8(28):46390-46397. PubMed ID: 28634318
[TBL] [Abstract][Full Text] [Related]
16. Apparent diffusion coefficient of diffusion weighted MRI in endometrial carcinoma-Relationship with local invasiveness.
Cao K; Gao M; Sun YS; Li YL; Sun Y; Gao YN; Zhang XP
Eur J Radiol; 2012 Aug; 81(8):1926-30. PubMed ID: 21592709
[TBL] [Abstract][Full Text] [Related]
17. Endometrial Carcinoma: Texture Analysis of Apparent Diffusion Coefficient Maps and Its Correlation with Histopathologic Findings and Prognosis.
Yamada I; Miyasaka N; Kobayashi D; Wakana K; Oshima N; Wakabayashi A; Sakamoto J; Saida Y; Tateishi U; Eishi Y
Radiol Imaging Cancer; 2019 Nov; 1(2):e190054. PubMed ID: 33778684
[TBL] [Abstract][Full Text] [Related]
18. Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer?
Yan B; Zhao T; Liang X; Niu C; Ding C
Acta Radiol; 2018 Mar; 59(3):363-370. PubMed ID: 28696169
[TBL] [Abstract][Full Text] [Related]
19. The role of diffusion magnetic resonance imaging in determining tumor aggressiveness during preoperative surgical planning in early-stage endometrial cancer.
Keven A; Yetim EE; Elmalı A; Arslan AG; Çubuk SM
Radiologie (Heidelb); 2023 Nov; 63(Suppl 2):41-48. PubMed ID: 37014376
[TBL] [Abstract][Full Text] [Related]
20. The value of multimodal functional magnetic resonance imaging in differentiating p53abn from p53wt endometrial carcinoma.
Shifeng T; Yue W; Wen Z; Lihua C; Nan W; Liangjie L; Ailian L
Acta Radiol; 2023 Nov; 64(11):2948-2956. PubMed ID: 37661630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
